Figure 1
From: Blood-borne miRNA profile-based diagnostic classifier for lung adenocarcinoma
Schematic diagram of our training-validation strategy for constructing a diagnostic classifier for lung adenocarcinoma.
We used 192 samples from 143 patients with lung adenocarcinoma (AD) and 49 from healthy subjects (HS) as a training cohort, while the independent validation cohort was comprised of 342 samples, including 110 AD, 27 squamous cell lung carcinoma (SQ), 10 large cell lung carcinoma (LC), 18 gastric cancer (GC), 20 colorectal cancer (CRC), 18 pancreatic cancer (Pan), 20 ovarian cancer (Ova) and 20 breast cancer (Br) cases, as well as 52 HS and 47 benign pulmonary disease (BPD) samples. TLDA, TaqMan low density array for miRNA expression analysis.
